Kawasaki disease natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Kawasaki disease}} {{CMG}}; {{AE}} ==Overview== If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestatio...")
 
 
(18 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Kawasaki disease}}
{{Kawasaki disease}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SH}}


==Overview==
==Overview==
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
If left untreated, the [[Symptom|symptoms]] will eventually relent, but [[Coronary artery aneurysm|coronary artery aneurysms]] will not improve, resulting in a significant risk of death or disability due to [[ST elevation myocardial infarction|myocardial infarction]]. If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short. [[Patient|Patients]] with Kawasaki disease may progress to develop long term [[Cardiovascular disease|cardiovascular]] illness such as [[Coronary heart disease|coronary artery disease]], and pre-mature [[atherosclerosis]]. Common [[Complication (medicine)|complications]] of Kawasaki disease include [[vasculitis]] and [[Aneurysm|coronary artery aneurysms]]. [[Prognosis]] is generally excellent and the mortality rate of [[Patient|patients]] with Kawasaki disease is approximately 2%.


OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
===Natural History===
===Natural History===
*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.  
* If left untreated, the [[Symptom|symptoms]] will eventually relent, but [[Coronary artery aneurysm|coronary artery aneurysms]] will not improve, resulting in a significant risk of death or disability due to [[ST elevation myocardial infarction|myocardial infarction]].
*The symptoms of (disease name) typically develop ___ years after exposure to ___.  
* If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short.  
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*[[Patient|Patients]] with Kawasaki disease may progress to develop long term [[Cardiovascular disease|cardiovascular]] illness such as [[Coronary heart disease|coronary artery disease]], and pre-mature [[atherosclerosis]].<ref name="pmid255183982">{{cite journal |vauthors=Kato H |title=[Natural history of Kawasaki disease vasculitis] |language=Japanese |journal=Nippon Rinsho |volume=72 |issue=9 |pages=1530–5 |date=September 2014 |pmid=25518398 |doi= |url=}}</ref>


===Complications===
===Complications===
*Common complications of [disease name] include:
* The [[cardiac]] complications are, by far, the most important aspect of Kawasaki disease:<ref>{{cite journal | author = Belay E, Maddox R, Holman R, Curns A, Ballah K, Schonberger L | title = Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. | journal = Pediatr Infect Dis J | volume = 25 | issue = 3 | pages = 245-9 | year = 2006 | id = PMID 16511388}}</ref><ref name="McCrindleRowley2017">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref>
**[Complication 1]
** Vasculitic changes in the [[coronary arteries]]
**[Complication 2]
**[[Coronary artery aneurysm|Coronary artery aneurysms]]
**[Complication 3]
*** These [[Aneurysm|aneurysms]] can lead to [[myocardial infarction]] even in young children. Overall, about 10 - 18% of children with Kawasaki disease develop [[Coronary artery aneurysm|coronary artery aneurysms]], with much higher [[prevalence]] among [[Patient|patients]] who are not treated early in the course of [[illness]].
*** Kawasaki disease is the most common cause of acquired [[heart disease]] among children in the United States.
 
* Other [[complications]] associated with Kawasaki disease are: <ref name="pmid41111">{{cite journal |vauthors=Amano S, Hazama F, Hamashima Y |title=Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes |journal=Jpn. Circ. J. |volume=43 |issue=7 |pages=633–43 |date=July 1979 |pmid=41111 |doi= |url=}}</ref>
{|
! style="background:#4479BA; color: #FFFFFF;" |Organ and Tissue
! style="background:#4479BA; color: #FFFFFF;" |Associated Conditions
|-
! style="background:#DCDCDC;" |[[Liver]]
| style="background:#DCDCDC;" |
* [[Hepatitis]]
|-
! style="background:#DCDCDC;" |[[Lung]]
| style="background:#DCDCDC;" |
* [[Interstitial pneumonitis]]
|-
! style="background:#DCDCDC;" |[[Gastrointestinal tract]]
| style="background:#DCDCDC;" |
* [[Abdominal pain]]
* [[Diarrhea]]
* [[Vomiting]]
* [[Gallbladder]] hydrops
|-
! style="background:#DCDCDC;" |[[Meninges]]
| style="background:#DCDCDC;" |
* [[Aseptic meningitis]]
* [[Irritability]]
|-
! style="background:#DCDCDC;" |[[Heart]]
| style="background:#DCDCDC;" |
* [[Myocarditis]]
* [[Pericarditis]]
* [[Valvulitis]]
|-
! style="background:#DCDCDC;" |[[Urinary tract]]
| style="background:#DCDCDC;" |
* [[Pyuria]]
|-
! style="background:#DCDCDC;" |[[Pancreas]]
| style="background:#DCDCDC;" |
* [[Pancreatitis]]
|-
! style="background:#DCDCDC;" |[[Lymph node|Lymph nodes]]
| style="background:#DCDCDC;" |
* [[Lymphadenopathy]]
|}


===Prognosis===
===Prognosis===
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
* With early treatment, rapid recovery from the acute [[Symptom|symptoms]] can be expected and the risk of [[Coronary artery aneurysm|coronary artery aneurysms]] greatly reduced.
*Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
*Untreated, the acute [[Symptom|symptoms]] of Kawasaki disease are self-limited, but the risk of [[Coronary arteries|coronary artery]] involvement is much greater.  
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
*[[Patient|Patients]] who have had Kawasaki disease should have an [[echocardiogram]] initially every few weeks, and then every 1 - 2 years to [[Screening (medicine)|screen]] for the progression of [[Heart|cardiac]] involvement.
*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
* Overall, about 2% of the [[Patient|patients]] die from [[Complication (medicine)|complications]] of [[coronary]] [[vasculitis]].
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
* It is also not uncommon that a [[relapse]] of symptoms may occur soon after initial treatment with [[IVIG]].
** This usually requires re-hospitalization and retreatment. Treatment with [[IVIG]] can cause allergic and non-allergic acute reactions, [[aseptic meningitis]], [[fluid overload]] and rarely other serious reactions.  
** [[Aspirin]] may increase the risk of [[bleeding]] from other causes and may be associated with [[Reye's syndrome]].  
** Overall, life-threatening complications resulting from therapy for Kawasaki disease are exceedingly rare, especially compared with the risk of non-treatment.


==References==
==References==
Line 39: Line 79:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
[[Category:Pediatrics]]
[[Category:Cardiovascular diseases]]
[[Category:Angiology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]
[[Category:Dermatology]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]

Latest revision as of 16:52, 14 February 2020

Kawasaki disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kawasaki disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kawasaki disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kawasaki disease natural history, complications and prognosis

CDC on Kawasaki disease natural history, complications and prognosis

Kawasaki disease natural history, complications and prognosis in the news

Blogs on Kawasaki disease natural history, complications and prognosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Kawasaki disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview

If left untreated, the symptoms will eventually relent, but coronary artery aneurysms will not improve, resulting in a significant risk of death or disability due to myocardial infarction. If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short. Patients with Kawasaki disease may progress to develop long term cardiovascular illness such as coronary artery disease, and pre-mature atherosclerosis. Common complications of Kawasaki disease include vasculitis and coronary artery aneurysms. Prognosis is generally excellent and the mortality rate of patients with Kawasaki disease is approximately 2%.

Natural History, Complications, and Prognosis

Natural History

Complications

Organ and Tissue Associated Conditions
Liver
Lung
Gastrointestinal tract
Meninges
Heart
Urinary tract
Pancreas
Lymph nodes

Prognosis

  • With early treatment, rapid recovery from the acute symptoms can be expected and the risk of coronary artery aneurysms greatly reduced.
  • Untreated, the acute symptoms of Kawasaki disease are self-limited, but the risk of coronary artery involvement is much greater.
  • Patients who have had Kawasaki disease should have an echocardiogram initially every few weeks, and then every 1 - 2 years to screen for the progression of cardiac involvement.
  • Overall, about 2% of the patients die from complications of coronary vasculitis.
  • It is also not uncommon that a relapse of symptoms may occur soon after initial treatment with IVIG.
    • This usually requires re-hospitalization and retreatment. Treatment with IVIG can cause allergic and non-allergic acute reactions, aseptic meningitis, fluid overload and rarely other serious reactions.
    • Aspirin may increase the risk of bleeding from other causes and may be associated with Reye's syndrome.
    • Overall, life-threatening complications resulting from therapy for Kawasaki disease are exceedingly rare, especially compared with the risk of non-treatment.

References

  1. ↑ Kato H (September 2014). "[Natural history of Kawasaki disease vasculitis]". Nippon Rinsho (in Japanese). 72 (9): 1530–5. PMID 25518398.
  2. ↑ Belay E, Maddox R, Holman R, Curns A, Ballah K, Schonberger L (2006). "Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003". Pediatr Infect Dis J. 25 (3): 245–9. PMID 16511388.
  3. ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.
  4. ↑ Amano S, Hazama F, Hamashima Y (July 1979). "Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes". Jpn. Circ. J. 43 (7): 633–43. PMID 41111.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Kawasaki_disease_natural_history,_complications_and_prognosis&oldid=1599008"